|
|
Personal data sheet |
Print preview VALIDITY EXPIRED This page was not yet approved. Publications |
2008
manual entry, 2009. III. 11. |
4 Ioannis Tsakiris, Gyorgyike Soos, Zoltan Nemes, Sandor Sz. Kiss, Csilla Andras,: The presence of carboxypeptidase-M in tumour cells, J Cancer Res Clin Oncol, pp. 439-451 type of document: Journal paper/Article impact factor: 2.469 language: English
|
2008
manual entry, 2009. III. 11. |
3 Judit Toth, Kristof Egervari, Almos Klekner, Laszlo Bognar, Janos Szanto, Zoltan: Analysis of EGFR Gene Amplification, Protein Over-, Pathol. Oncol. Res., pp. 12253-008 type of document: Journal paper/Article impact factor: 1.241 language: English
|
2008
manual entry, 2009. III. 11. |
Éva Szekanecz, Gabriella Szűcs, Zoltán Szekanecz, Tünde Tarr, Péter Antal-Szalmás,: Tumor-associated antigens in systemic, Journal of Autoimmunity, pp. 1-5 type of document: Journal paper/Article impact factor: 2.154 language: English
|
2007
manual entry, 2009. III. 11. |
8 Szekanecz É., Sándor Z., Antal-Szalmás P., Soós L., Lakos G., Besenyei T.,: Increased production of the soluble tumor-associated antigens CA 19-9, CA 125 and CA 15-3 in rheumatoid arthritis: potential adhesion molecules in synovial inflammation?, Ann NY Acad Sci, pp. 349-358 type of document: Journal paper/Article impact factor: 1.930 language: English
|
2006
manual entry, 2009. III. 11. |
13 É. Szekanecz, Cs. András, Zs. Sándor, P. Antal-Szalmás, J. Szántó, L. Tamási, E. Kiss, Z. Szekanecz: Malignancies and soluble tumor antigens in rheumatic diseases, Autoimmunity Reviews, pp. 42-47 type of document: Journal paper/Article impact factor: 3.091 language: English
|
2005
manual entry, 2009. III. 11. |
21 C. Zielinski, S. Beslija, Z. Mrsic-Krmpotic, J. Szanto, et al: Gemcitabine, Epirubicin, and Paclitaxel Versus Fluorouracil, Epirubicin, and Cyclophosphamide As First-Line Chemotherapy in Metastatic Breast Cancer: A Central European Cooperative Oncology Group International, Multicenter, Prospective, Randomized, Phase III Trial, J Clin Oncol, pp. 1401-1408 type of document: Journal paper/Article impact factor: 11.810 language: English
|
2005
manual entry, 2009. III. 11. |
19 Soós, I. Tsakiris, J. Szántó, C. Thurzó, G. Haas, B. Dezső: The prevalence of prostate carcinoma and its precursor in Hungary: An autopsy study, Eur Urol, pp. 739-744 type of document: Journal paper/Article impact factor: 3.542 language: English
|
2004
manual entry, 2009. III. 11. |
27 J. Szántó, C. András, J. Tsakiris, S. Gomba, Z. Szentirmay, S. Bánlaki, I. Szilágyi, C. Kiss, P. Antall, Á. Horváth, L. Lengyel, M. Castiglione-Gertsch: Secretory breast cancer in a 7.5-year old boy, Breast, pp. 439-442 type of document: Journal paper/Article impact factor: 0.760 language: English
|
2004
manual entry, 2009. III. 11. |
24 C. Pozzo, C. Barone, J. Szanto, E. Padi, C. Peschel, J. Bükki, V. Gorbunova, V. Valvere, J. Zaluski, M. Biakhov, E. Zuber, C. Jacques & R. Bugat: Irinotecan in combination with 5-fluorouracil and folinic acid or with cisplatin in patients with advanced gastric or esophageal-gastric junction adenocarcinoma: results of a randomized phase II study, Ann Oncol, pp. 1773-1781 type of document: Journal paper/Article impact factor: 4.335 language: English
|
2003
manual entry, 2009. III. 11. |
Boér K, Láng I, Juhos E, Pintér T, Szántó J.: Adjuvant therapy of breast cancer with docetaxel-containing combination (TAC)., Epub 2003 Oct 7, pp. 165-169 type of document: Journal paper/Article impact factor: 1.241 language: English
|
| Number of independent citations to these publications: | 0 |
|
|
|
|
|